Ardelyx (ARDX) Other Working Capital Changes (2013 - 2026)
Ardelyx posted quarterly Other Working Capital Changes of $2.0 million for Q1 2026, up 271.45% year-on-year from $549733.7 in Q1 2025, and up 232.68% on a QoQ basis from -$1.5 million in Q4 2025.
Ardelyx (ARDX) has 14 years of Other Working Capital Changes data on file, last reported at $2.0 million in Q1 2026.
- For the quarter ending Q1 2026, Other Working Capital Changes rose 271.45% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $220000.0 (up 104.84% YoY), and the FY2025 full-year result was -$3.0 million, down 244.02% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $2.0 million, up from -$1.5 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $6.4 million in Q3 2024 and bottomed at -$7.6 million in Q2 2024.
- The 5-year median for Other Working Capital Changes is $609000.0 (2025), against an average of $258588.2.
- The widest annual swing landed in 2023, when Other Working Capital Changes soared 386.46%; it then sank 2522.22% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $1.4 million in 2022, then tumbled by 105.63% to -$81000.0 in 2023, then tumbled by 2522.22% to -$2.1 million in 2024, then gained by 27.54% to -$1.5 million in 2025, then jumped by 232.68% to $2.0 million in 2026.
- The last three Other Working Capital Changes figures came in at $2.0 million (Q1 2026), -$1.5 million (Q4 2025), and $609000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Dec 31, 2025 | -1.54 Mn |
| Sep 30, 2025 | 609,000.00 |
| Sep 30, 2025 | 609,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Jun 30, 2025 | -892,000.00 |
| Mar 31, 2025 | -1.19 Mn |
| Mar 31, 2025 | -1.19 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Dec 31, 2024 | -2.12 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Sep 30, 2024 | 6.42 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Jun 30, 2024 | -7.65 Mn |
| Mar 31, 2024 | 5.45 Mn |
| Mar 31, 2024 | 5.45 Mn |
| Dec 31, 2023 | -81,000.00 |
| Dec 31, 2023 | -81,000.00 |
| Sep 30, 2023 | 4.56 Mn |
| Sep 30, 2023 | 4.56 Mn |
| Jun 30, 2023 | -5.70 Mn |
| Jun 30, 2023 | -5.70 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Mar 31, 2023 | 3.81 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | 938,000.00 |
| Sep 30, 2022 | 938,000.00 |
| Jun 30, 2022 | -5.53 Mn |
| Jun 30, 2022 | -5.53 Mn |
| Mar 31, 2022 | 3.84 Mn |
| Mar 31, 2022 | 3.84 Mn |
| Dec 31, 2021 | -1.83 Mn |
| Dec 31, 2021 | -1.83 Mn |
| Sep 30, 2021 | -1.21 Mn |
| Sep 30, 2021 | -1.21 Mn |
| Jun 30, 2021 | -13.48 Mn |
| Jun 30, 2021 | -13.48 Mn |
| Mar 31, 2021 | 13.66 Mn |
| Mar 31, 2021 | 13.66 Mn |
| Dec 31, 2020 | 1.05 Mn |
| Dec 31, 2020 | 1.05 Mn |
| Sep 30, 2020 | -2.41 Mn |
| Sep 30, 2020 | -2.41 Mn |
| Jun 30, 2020 | -637,000.00 |
| Jun 30, 2020 | -637,000.00 |
| Mar 31, 2020 | -614,000.00 |
| Mar 31, 2020 | -614,000.00 |
| Dec 31, 2019 | -4.96 Mn |
| Dec 31, 2019 | -4.96 Mn |
| Sep 30, 2019 | 3.08 Mn |
| Sep 30, 2019 | 3.08 Mn |
| Jun 30, 2019 | 399,000.00 |
| Jun 30, 2019 | 399,000.00 |
| Mar 31, 2019 | -411,000.00 |
| Mar 31, 2019 | -411,000.00 |
| Dec 31, 2018 | -4.43 Mn |
| Dec 31, 2018 | -4.43 Mn |
| Sep 30, 2018 | 5.10 Mn |
| Sep 30, 2018 | 5.10 Mn |
| Jun 30, 2018 | 813,000.00 |
| Jun 30, 2018 | 813,000.00 |
| Mar 31, 2018 | -2.01 Mn |
| Mar 31, 2018 | -2.01 Mn |
| Dec 31, 2017 | -30,000.00 |
| Dec 31, 2017 | -30,000.00 |
| Sep 30, 2017 | -783,000.00 |
| Sep 30, 2017 | -783,000.00 |
| Jun 30, 2017 | 733,000.00 |
| Jun 30, 2017 | 733,000.00 |
| Mar 31, 2017 | 2.23 Mn |
| Mar 31, 2017 | 2.23 Mn |
| Dec 31, 2016 | -843,000.00 |
| Dec 31, 2016 | -843,000.00 |
| Sep 30, 2016 | 354,000.00 |
| Sep 30, 2016 | 354,000.00 |
| Jun 30, 2016 | -192,000.00 |
| Jun 30, 2016 | -192,000.00 |
| Mar 31, 2016 | -881,000.00 |
| Mar 31, 2016 | -881,000.00 |
| Dec 31, 2015 | 51.14 Mn |
| Dec 31, 2015 | 51.14 Mn |
| Jun 30, 2015 | -43.14 Mn |
| Jun 30, 2015 | -43.14 Mn |
| Mar 31, 2015 | -3.91 Mn |
| Mar 31, 2015 | -3.91 Mn |
| Dec 31, 2014 | -11.24 Mn |
| Dec 31, 2014 | -11.24 Mn |
| Sep 30, 2014 | 11.14 Mn |
| Sep 30, 2014 | 11.14 Mn |
| Jun 30, 2014 | -298,000.00 |
| Jun 30, 2014 | -298,000.00 |
| Mar 31, 2014 | 296,000.00 |
| Mar 31, 2014 | 296,000.00 |
| Dec 31, 2013 | 7.28 Mn |
| Dec 31, 2013 | 7.28 Mn |
| Sep 30, 2013 | 3.22 Mn |
| Sep 30, 2013 | 3.22 Mn |